Web Access Research Portal

Researcher: Salahudeen, MS (Dr Mohammed Salahudeen)

Fields of Research

Clinical pharmacy and pharmacy practice
Clinical pharmacology and therapeutics
Geriatrics and gerontology
Aged health care
Sports medicine
Health promotion
Intensive care
Community child health
Infectious diseases
Continuing and community education
Orthodontics and dentofacial orthopaedics
Toxicology (incl. clinical toxicology)
Social psychology
Environment and resource economics
Acute care

Research Objectives

Evaluation of health outcomes
Health education and promotion
Evaluation of health and support services
Health related to ageing
Efficacy of medications
Clinical health
Diagnosis of human diseases and conditions
Mental health
Provision of health and support services
Higher education
Primary care
Health status (incl. wellbeing)
Preventive medicine
Other health
Prevention of human diseases and conditions
Neonatal and child health
Specific population health (excl. Indigenous health)
Behaviour and health
Public health (excl. specific population health)
Men's health

Career Best Publications

Research Publications

A comparison of anticholinergic risk scales and associations to adverse health outcomes in older people; 2014 FIP Congress in PSWC
A review of current evidence allied to step-up and top-down medication therapy in inflammatory bowel disease; Drugs of Today
A study of the factors affecting time to onset of lactogenesis-II after parturition; Journal of Pharmacy Research
A study on drug–drug interactions through prescription analysis in a South Indian teaching hospital; Therapeutic advances in drug safety
A systematic review and meta-analysis on serum anticholinergic activity and adverse outcomes in older people
A systematic review and meta-analysis on serum anticholinergic activity and adverse outcomes in older people; ASCEPT-APSA conference
A Systematic Review Evaluating the Use of the interRAI Home Care Instrument in Research for Older People; Clinical gerontologist
Actual drug-related harms in residential aged care facilities: a narrative review; Expert Opinion on Drug Safety
Adverse drug reaction-related hospitalisations among people with dementia; APSA-ASCEPT 2022 Joint Conference
An overview of available computer-based simulation tools in pharmacy practice education; APSA 2021 Annual Conference
An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice; Saudi pharmaceutical journal
An overview of pharmacoepidemiology in New Zealand: medical databases, registries and research achievements; The New Zealand medical journal
Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review; BMC geriatrics
Anticholinergics: theoretical and clinical overview; Expert opinion on drug safety
Association between anticholinergic drug burden and mortality in older people: a systematic review; European Journal of Clinical Pharmacology
Association between anticholinergic drug burden and mortality in older people: an evidence-based approach; 79th FIP World Congress of Pharmacy and Pharmaceutical Sciences
Australian pharmacists' opinions of their CPD requirements; OnShore Refresher Conference
Barriers and facilitators impacting the uptake of computer-based simulation in pharmacy education; Digital Health Week 2022
Cognitive adverse effects and brain deterioration associated with use of anticholinergic activity medicines in older adults; Evidence - Based Medicine (English Edition): for primary care and internal medicine
Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulants; Expert Review of Clinical Pharmacology
Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people; Journal of the American Geriatrics Society
Credentials for a PharmD graduate: The voyage never ends; SAGE open medicine
Deprescribing medications in older people: a narrative review; Drugs of Today
Drug-associated hyperthermia: A longitudinal analysis of hospital presentations; Journal of Clinical Pharmacy and Therapeutics
Drug-associated non-pyrogenic hyperthermia: a narrative review; European Journal of Clinical Pharmacology
Effectiveness of interventions to improve the anticholinergic prescribing practice in older adults: a systematic review; Journal of Clinical Medicine
Eight-year trends in direct-acting oral anticoagulant dosing, based on age and kidney function, in patients with atrial fibrillation; Journal of Patient Safety
Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review; Therapeutic Advances in Drug Safety
Estimating the relative potencies of an anticholinergic medicine: A methodological view point; PAGANZ conference 2014
Examination and Estimation of Anticholinergic Burden
Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research; Drugs and Aging
Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillation; European Journal of Clinical Investigation
Five-year trends in potential drug interactions with direct-acting oral anticoagulants in patients with atrial fibrillation: an Australian-wide study; Journal of Clinical Medicine
Geriatric Safe Medicines and Medication Management: Application of the interRAI home care assessments in Geriatric Research and Medication Management; BIT’s 5th Annual World Congress of Geriatrics and Gerontology
Impact of anticholinergic discontinuation on cognitive outcomes in older people; 2013 Australasian Pharmaceutical Science Association (APSA)
Impact of Anticholinergic Discontinuation on Cognitive Outcomes in Older People: A Systematic Review; Drugs & Aging
Impact of partnered pharmacist medication charting in the Royal Hobart Hospital emergency department on medication discrepancies and errors: preliminary results; APSA 2021 Annual Conference
Impact of pharmacist interventions provided in the emergency department on quality use of medicines: a systematic review and meta-analysis; Emergency Medicine Journal
Invited Chair; BIT’s 5th Annual World Congress of Geriatrics and Gerontology -2017
Model-based estimation of anticholinergic burden; PAGANZ conference
Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: a population-based cohort study; Journal of the American Heart Association
Outcomes of medication misadventure among people with cognitive impairment or dementia: a systematic review and meta-analysis; The Annals of Pharmacotherapy
Pharmacist-led interventions to reduce adverse drug events in older people living in residential aged care facilities: a systematic review; British Journal of Clinical Pharmacology
Pharmacists as a Source of Advice on Medication Use for Athletes; Pharmacy
Pharmacist’s interventions to reduce the occurrence of drug-related harms in older residents: a systematic review; APSA 2021 Annual Conference
Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk; Journal of Clinical Pharmacy and Therapeutics
Risk of osteoporosis in patients with atrial fibrillation with and without oral anticoagulant therapy; Expert Review of Clinical Pharmacology
Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature; PloS one
Stroke risk reassessment and oral anticoagulant initiation in primary care patients with atrial fibrillation: a ten-year follow-up; European Journal of Clinical Investigation
Study on the classification, causality, preventability and severity of adverse drug reaction using spontaneous reporting system in hospitalized patients; Pharmacy
Temporal trends in Polypharmacy and Hyperpolypharmacy in older New Zealanders over a 9-Year period: 2005–2013; Gerontology
Temporal trends in the use of antidiabetic medicines: a nationwide 9-year study in older people living in New Zealand; Therapeutic advances in drug safety
Ten-year trends in adverse drug reaction-related hospitalizations among people with dementia; Therapeutic Advances in Drug Safety
Ten-year trends in prescribing of antiarrhythmic drugs in Australian primary care patients with atrial fibrillation; Internal Medicine Journal
Ten-Year trends in the use of oral anticoagulants in Australian general practice patients with atrial fibrillation; Frontiers in Pharmacology
The Influence of Patient Characteristics on Anticholinergic Events in Older People; Dementia and geriatric cognitive disorders extra

Research Projects

Adverse drug reaction-related hospital admission in elderly Australians with dementia; Royal Hobart Hospital Research Foundation (RHHRF)
Intervention to lessen anticholinergic drug burden in hospitalised older adults; Royal Hobart Hospital Research Foundation (RHHRF)

Research Candidate Supervision